MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 08.05.2026
Land |
 Schweiz |
IPO-Jahr |
1997 |
Branche |
Diagnostik & Forschung |
Börse |
NYSESPB |
Anteile |
20.6 M |
Marktkapitalisierung |
$ 23.5 B |
EBITDA (LTM) |
$ 51.2 M |
P/E (LTM) |
30.75 |
P/S (LTM) |
6.03 |
EPS (LTM) |
36.57 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE |  USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 203.83 | 0.02 % | $ 22.6 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 89.49 | 1.42 % | $ 4.18 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 4.7 | -3.69 % | $ 6.25 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.78 | -0.79 % | $ 578 M | Nasdaq Global Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.01 | -0.33 % | $ 609 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 149.92 | 3.69 % | $ 11.8 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 166.21 | 2.3 % | $ 25.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Guardant Health
GH
|
$ 130.9 | 0.15 % | $ 16.4 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 23.66 | 0.85 % | $ 1.26 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Interpace Biosciences
IDXG
|
$ 1.65 | -6.41 % | $ 7.3 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 104.32 | 4.07 % | $ 7.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.35 | -1.46 % | $ 405 M | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 188.06 | 0.95 % | $ 9.32 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 475.07 | 2.01 % | $ 13.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 11.47 | 1.68 % | $ 1.47 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.63 | 4.51 % | $ 429 M | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.79 | -11.7 % | $ 421 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 219.23 | 1.26 % | $ 30 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 9.42 | -1.98 % | $ 841 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.11 | 1.71 % | $ 24.8 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 7.33 | 0.41 % | $ 306 M | NYSE American | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 74.05 | 9.27 % | $ 4.43 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.09 | 3.47 % | $ 4.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 265.27 | -1.26 % | $ 22.1 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 475.66 | -1.32 % | $ 179 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.68 | -1.82 % | $ 244 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.24 | 0.82 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |